In human colitis-associated colon cancers, TP53 mutations are the most common founder mutations and are also found in non-tumorous inflamed mucosa, possibly caused by reactive oxygen species generation (Hussain et al., 2000; Leedham et al., 2009; Thorsteinsdottir et al., 2011). Here, TP53 is linked to colonic neoplasm.